Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Immunol. 2012 Apr 25;188(11):5766–5775. doi: 10.4049/jimmunol.1102930

Table I.

MHC binding capacity of mouse peptides recognized by islet-infiltrating HLA-restricted T cells in HLA-transgenic NOD mice and their human equivalents

A: HLA-A*1101-transgenic NOD mice
Binding to A3 supertype members (IC50, nM)

Organism Position Sequence A*1101 A*0301 A*3001 A*3101 A*3301 A*6601 A*6801
Mouse IGRP 272–280 AINSEMFLRa 209 428 49752 67 1081 4547 109
Human IGRP 272–280 AINSEMFLL 2824 1258 6776 1071 12784 36672 14186

Mouse Ins1 C21-30 TLALEVARQK 3327 605 23280 13026 25455 b 13432
Mouse Ins2 C23-32 TLALEVAQQK 833 856 7494
Human Ins C23-32 PLALEGSLQKc 37072 20873 39403 48509 41456

Mouse Ins1 C22-31 LALEVARQKR 43592 42979 10808 9145 12966 12582
Human Ins C24-33 LALEGSLQKR 34461 17521 38387 3271 515 66
B: HLA-B*0702-transgenic NOD mice
Binding to B7 supertype members (IC50, nM)

Organism Position Sequence B*0702 B*3501 B*3503 B*4201 B*5101 B*5301 B*5401
Mouse Ins1 C15-24 SPGDLQTLAL 4.4 16115 35 10987
Human Ins C15-26 GPGAGSLQPLAL 462 6066 15456
a

bold and underlined letters indicate amino acid identity between murine and human peptides

b

dash indicates IC50 > 50000 nM

c

recently reported as an HLA-A3-restricted epitope in humans (26)

HHS Vulnerability Disclosure